Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: A systematic review and meta-analysis

American Journal of Gastroenterology

Volumn 109, Issue 6, 2014, Pages 811-819

  Anglin, Rebecca ^a   Yuan, Yuhong ^a   Moayyedi, Paul ^a   Tse, Frances ^a   Armstrong, David ^a   Leontiadis, Grigorios I ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT DISEASE; ANTICOAGULANT THERAPY; CASE CONTROL STUDY; COHORT ANALYSIS; HUMAN; INCIDENCE; LOW RISK POPULATION; META ANALYSIS; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK; RISK FACTOR; RISK REDUCTION; SYSTEMATIC REVIEW; UPPER GASTROINTESTINAL BLEEDING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG THERAPY, COMBINATION; GASTROINTESTINAL HEMORRHAGE; HUMANS; INCIDENCE; RISK ASSESSMENT; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; UPPER GASTROINTESTINAL TRACT;

EID: 84902074364     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2014.82     Document Type: Review

References (44)

1. Hemels ME, Koren G, Einarson TR. Increased use of antidepressants in Canada: 1981-2000. Ann Pharmacother 2002;36;1375-9
2. MacGillivray S, Arroll B, Hatcher S, et al. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: Systematic review and meta-Analysis. BMJ 2003;326;1014
3. Serebruany VL. Selective serotonin reuptake inhibitors and increased bleeding risk: Are we missing something?. Am J Med 2006;119;113-6. (Pubitemid 43151473
4. Loke YK, Trivedi AN, Singh S. Meta-Analysis: Gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and nonsteroidal anti-infl ammatory drugs. Alim Pharmacol Ther 2008;27;31-40. (Pubitemid 350212624
5. Halperin D, Reber G. Infl uence of antidepressants on hemostasis. Dialogues Clin Neurosci 2007;9;47-59
6. Li N, Wallen NH, Ladjevardi M, et al. Eff ects of serotonin on platelet activation in whole blood. Blood Coagul Fibrinolysis 1997;8;517-23. (Pubitemid 28023394
7. Andrade C, Sandarsh S, Chethan KB, et al. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: A review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry 2010;71;1565-75
8. Abdel Salam OM. Fluoxetine and sertraline stimulate gastric acid secretion via a vagal pathway in anaesthetised rats. Pharmacol Res 2004;50;309-16. (Pubitemid 38844486
9. Carvajal A, Ortega S, Del Olmo L, et al. Selective serotonin reuptake inhibitors and gastrointestinal bleeding: A case-control study. PloS One 2011;6;e19819
10. Dall M, Schaff alitzky de Muckadell OB, Lassen AT, et al. An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding. Clin Gastroenterol Hepatol 2009;7;1314-21
11. de Abajo FJ, Garcia-Rodriguez LA. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: Interaction with nonsteroidal anti-infl ammatory drugs and Effect of acid-suppressing agents. Arch Gen Psychiatry 2008;65;795-803. (Pubitemid 351957705
12. Lin KJ, Hernandez-Diaz S, Garcia Rodriguez LA. Acid suppressants reduce risk of gastrointestinal bleeding in patients on antithrombotic or anti-infl ammatory therapy. Gastroenterology 2011;141;71-9
13. Opatrny L, Delaney JA, Suissa S. Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: A new look. Br J Clin Pharmacol 2008;66;76-81. (Pubitemid 351822152
14. Soberg T, Hofstad B, Sandvik L, et al. Risk factors for peptic ulcer bleeding. Tidsskr Nor Laegeforen 2010;130;1135-9
15. Targownik LE, Bolton JM, Metge CJ, et al. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding. Am J Gastroenterol 2009;104;1475-82
16. Vidal X, Ibanez L, Vendrell L, et al. Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants: A case-control study. Drug Saf 2008;31;159-68. (Pubitemid 351158526
17. de Abajo FJ, Gil MJ, Bryant V, et al. Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: A nested casecontrol study in a new general practice database. Eur J Clin Pharmacol 2013;69;691-701
18. Hreinsson JP, Kalaitzakis E, Gudmundsson S, et al. Upper gastrointestinal bleeding: Incidence, etiology and outcomes in a population-based setting. Scand J Gastroenterol 2013;48;439-47
19. Hreinsson JP, Gumundsson S, Kalaitzakis E, et al. Lower gastrointestinal bleeding: Incidence, etiology, and outcomes in a population-based setting. Eur J Gastroenterol Hepatol 2013;25;37-43
20. Lewis JD, Strom BL, Localio AR, et al. Moderate and high affi nity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity. Pharmacoepidemiol Drug Saf 2008;17;328-35. (Pubitemid 351566348
21. Barbui C, Andretta M, De Vitis G, et al. Antidepressant drug prescription and risk of abnormal bleeding: A case-control study. J Clin Psychopharmacol 2009;29;33-8
22. Verdel BM, Souverein PC, Meenks SD, et al. Use of serotonergic drugs and the risk of bleeding. Clin Pharmacol Ther 2011;89;89-96
23. Vonbach P, Reich R, Moll F, et al. Risk factors for gastrointestinal bleeding: A hospital-based case-control study. Swiss Med Wkly 2007;137;705-10
24. Coupland C, Dhiman P, Morriss R, et al. Antidepressant use and risk of adverse outcomes in older people: Population based cohort study. BMJ 2011;343;d4551
25. Sheehan DV JV, Choi JC, Camacho F. Risk of upper gastrointestinal hemorrhage in elderly selective serotonin/norepinephrine reuptake inhibitor users. In: AAGP Annual Meeting 2009; March 2009; Honolulu, HI; 2009, A94
26. Huang ES KH, Strate LL, Chan AT. Selective serotonin reuptake inhibitors and risk of gatrointestinal bleeding in two prospective, population-based cohorts. In: Digestive Disease Week, May 2011; Chicago, IL, USA; 2011 S-137
27. Wells GAS B., O ' Connell, D. . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-Analyses. (cited 1 February 2011) Available from: Http://www.ohri.ca/programs/clinical- epidemiology/oxford.htm
28. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-Analyses. BMJ 2003;327;557-60
29. Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-Analyses of randomised controlled trials. BMJ 2011;343;d4002
30. van Leerdam ME, Vreeburg EM, Rauws EA, et al. Acute upper GI bleeding: Did anything change?. Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993/1994 and 2000. Am J Gastroenterol 2003;98;1494-9
31. Lewis JD, Bilker WB, Brensinger C, et al. Hospitalization and mortality rates from peptic ulcer disease and GI bleeding in the 1990s: Relationship to sales of nonsteroidal anti-infl ammatory drugs and acid suppression medications. Am J Gastroenterol 2002;97;2540-9
32. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998;88;15-9
33. Meijer WE, Heerdink ER, Leufk ens HG, et al. Incidence and determinants of long-Term use of antidepressants. Eur J Clin Pharmacol 2004;60;57-61. (Pubitemid 38471459
34. Paulose-Ram R, Safran MA, Jonas BS, et al. Trends in psychotropic medication use among US adults. Pharmacoepidemiol Drug Saf 2007;16;560-70. (Pubitemid 46824278
35. Andersson T, Alfredsson L, Kallberg H, et al. Calculating measures of biological interaction. Eur J Epidemiol 2005;20;575-9. (Pubitemid 41126030
36. de Abajo FJ, Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: Population based case-control study. BMJ 1999;319;1106-9. (Pubitemid 29494721
37. Tata LJ, Fortun PJ, Hubbard RB, et al. Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-infl ammatory drugs substantially increase the risk of upper gastrointestinal bleeding?. Alim Pharmacol Ther 2005;22;175-81
38. Norgard B, Pedersen L, Johnsen SP, et al. COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: A population-based case-control study. Alim Pharmacol Ther 2004;19;817-25. (Pubitemid 38496648
39. Wessinger S, Kaplan M, Choi L, et al. Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: A multicentre retrospective analysis. Alim Pharmacol Ther 2006;23;937-44
40. Dalton SO, Johansen C, Mellemkjaer L, et al. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: A population-based cohort study. Arch Int Med 2003;163;59-64. (Pubitemid 36091601
41. Ford AC, Talley NJ, Schoenfeld PS, et al. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: Systematic review and meta-Analysis. Gut 2009;58;367-78
42. Mercier A, Auger-Aubin I, Lebeau JP, et al. Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: An analysis of guidelines and systematic reviews. BMC Fam Pract 2013;14;55
43. Rostom A, Dube C, Wells G, et al. Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev 2002;4;CD002296
44. Rostom A, Moayyedi P, Hunt R. Canadian consensus guidelines on long-Term nonsteroidal anti-infl ammatory drug therapy and the need for gastroprotection: Benefi ts versus risks. Alim Pharmacol Ther 2009;29;481-96